Ovarian cancer lacks effective screening, making early detection difficult; symptoms are often non-specific and include bloating, early satiety, and abdominal pain. Diagnosis involves imaging, biopsy, ...

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes. Your diagnosis of an early-stage (Stage 1) gynecologic ...

High-risk advanced ovarian cancer patients showed marginal survival benefit with bevacizumab added to first-line chemotherapy. Patients without high-risk characteristics did not show significant ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...